Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARTV compared with ABOS: revenue, margins and what each company keeps, and the suppliers and customers both name
ARTV
Artiva Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ABOS
Acumen Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARTV
Artiva Biotherapeutics, Inc.
vs
ABOS
Acumen Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ARTV, solid
ABOS, dashed
ARTV
Artiva Biotherapeutics, Inc.
Change
4.19
· pre 4.19
· delayed
Mkt cap
$204.8M
Revenue
$251,000
Q1 FY24
ABOS
Acumen Pharmaceuticals, Inc.
Change
0.22
· pre 0.23
Pre-market
Sep 2 '83
Mkt cap
$15.2M
Revenue
—
vs
Compare
Pre-market
Sep 2 '83
ARTV
Artiva Biotherapeutics, Inc.
vs
ABOS
Acumen Pharmaceuticals, Inc.
4.19
pre 4.19
delayed
Price
0.22
pre 0.23
$204.8M
Mkt cap
$15.2M
Q1 FY24
$251,000
Revenue
—
Change
Change
ARTV
4.19
vs
ABOS
0.22
Pre-market
Sep 2 '83